503A vs 503B (pharmacy compounding)
Compounded vs FDA-approved, 503A vs 503B, and the accreditation programs that distinguish them.
Definition
Two FDA categories for sterile compounding pharmacies. 503A: state-licensed pharmacies that compound patient-specific prescriptions (must hold a valid prescription with a named patient). 503B: voluntarily-registered outsourcing facilities that can compound in bulk without prescriptions, must comply with full Current Good Manufacturing Practice (cGMP) standards.
Definition curated by Weight Loss Rankings — sourced from FDA labels and peer-reviewed PubMed literature, never AI-generated summaries.
503A vs 503B (pharmacy compounding) in plain English
Both numbers refer to sections of the Federal Food, Drug, and Cosmetic Act, and the difference between them is the single most useful thing a patient can know when weighing a compounded GLP-1.
A 503A pharmacy is a traditional state-licensed compounding pharmacy. It prepares medication for an individual patient with an individual prescription. FDA says state boards of pharmacy have primary responsibility for day-to-day oversight of these pharmacies, though FDA does conduct surveillance and for-cause inspections. Critically, FDA states that drugs compounded under section 503A are not subject to current good manufacturing practice requirements.
A 503B outsourcing facility voluntarily registers with FDA. In exchange it may compound in batches without a patient-specific prescription, and it takes on the obligations that come with that: outsourcing facilities are primarily overseen and inspected by FDA on a risk-based schedule, and the drugs they compound are subject to CGMP requirements — the same manufacturing-quality framework that applies to commercial drug production.
Two clarifications people routinely get wrong. First, neither category means FDA-approved. A compounded drug has not been reviewed for safety, effectiveness or manufacturing quality the way an approved product has, regardless of which section it was made under. Second, FDA states that biological products are not eligible for the compounding exemptions under either 503A or 503B — there is no legal pathway to compound a biologic outside an approved biologics license application, which matters for several peptides sold online.
Worth asking before you buy: which section the pharmacy operates under, whether it is registered with FDA as an outsourcing facility (that registry is public), what the source of the active ingredient is, and whether a licensed clinician wrote a prescription specifically for you. Our pharmacy legitimacy lookup and the compounded-versus-brand questions hub walk through the checks, and our compounded semaglutide rankings show how we weigh them.
Related terms in Pharmacy and drug forms
Looking for more depth?
- Compounded vs brand Q&A hub
- Browse the full GLP-1 glossary (124 terms across 8 categories)
- Research articles — primary-source deep dives
- Tools and calculators
- Compare GLP-1 telehealth providers